Walmart announced it will cover over 250 prescriptions at no cost to employees starting in 2027, including insulin, inhalers, and diabetes drugs Ozempic and Mounjaro for Type 2 diabetes after prior authorization. This move aims to attract and retain workers by expanding benefits amid rising healthcare costs elsewhere. Walmart is also enhancing other benefits like specialist second opinions for rare diseases and additional neonatal ICU leave. The company is keeping premium increases minimal, signaling a continued effort to improve employee compensation and healthcare offerings.
Walmart's market cap stands at $897.15 billion as of Oct 14, 2026, with a dividend yield of 0.88%. The stock price on Pluang is $113.06, showing a slight 0.02% decline on the day. Trading volume is robust at 13,691,712 shares, reflecting active investor interest as the company expands employee benefits.
The state of California alleges that Amazon is involved in a price-fixing scheme that coerces wholesale vendors to increase prices at competing retailers such as Target, Walmart, Chewy, and Best Buy. Evidence includes email exchanges between Amazon v...
Walmart's effort to automate warehouses with robots faces challenges as the machines struggle to handle heavy items like turkeys and dog food, and cannot manage the long-used cardboard boxes designed for human workers. To address this, Walmart plans ...
Walmart and JPMorgan Chase are nearly tied in market value, with less than $4 billion separating them. Walmart was valued at $877.15 billion and JPMorgan at $880.98 billion as of October 8, 2026. The companies operate in very different sectors—retail...
